|
AcelRx Pharmaceuticals
ACRX
|
$ 0.86 |
7.5 % |
$ 6.35 M |
Nasdaq Global Market |
USA |
|
Amryt Pharma plc
AMYT
|
$ 14.7 |
- |
$ 621 M |
Nasdaq Global Select Market |
Britain |
|
Aerie Pharmaceuticals
AERI
|
$ 15.25 |
- |
$ 754 M |
Nasdaq Global Market,SPB |
USA |
|
PetIQ
PETQ
|
$ 13.6 |
1.64 % |
$ 400 M |
Nasdaq Global Select Market,SPB |
USA |
|
Agile Therapeutics
AGRX
|
$ 0.6 |
10.11 % |
$ 58.2 M |
Nasdaq Capital Market |
USA |
|
Teligent, Inc.
TLGT
|
$ 0.173 |
-13.85 % |
$ 16.1 M |
Nasdaq Global Select Market |
USA |
|
Recro Pharma
REPH
|
$ 1.4 |
-4.76 % |
$ 65.3 M |
Nasdaq Global Select Market |
USA |
|
Athenex
ATNX
|
$ 0.2 |
-23.39 % |
$ 1.76 M |
Nasdaq Global Select Market |
USA |
|
PLx Pharma
PLXP
|
$ 0.09 |
-27.8 % |
$ 2.56 M |
Nasdaq Capital Market |
USA |
|
Shineco, Inc.
TYHT
|
$ 11.09 |
-3.90 % |
$ 97.2 M |
Nasdaq Global Select Market |
China |
|
Elanco Animal Health Incorporated
ELAN
|
$ 12.55 |
-0.4 % |
$ 6.18 B |
NYSE,SPB |
USA |
|
Lannett Company
LCI
|
$ 0.66 |
1.15 % |
$ 7.11 M |
NYSE |
USA |
|
Calliditas Therapeutics AB (publ)
CALT
|
$ 40.0 |
-0.1 % |
$ 2.03 B |
Nasdaq Global Select Market |
Schweden |
|
GW Pharmaceuticals plc
GWPH
|
$ 218.96 |
- |
$ 6.81 B |
Nasdaq Global Select Market |
Britain |
|
Adamas Pharmaceuticals, Inc.
ADMS
|
$ 8.22 |
- |
$ 376 M |
Nasdaq Global Market |
USA |
|
Phibro Animal Health Corporation
PAHC
|
$ 22.37 |
-3.49 % |
$ 906 M |
Nasdaq Global Market,SPB |
USA |
|
Pacira BioSciences
PCRX
|
$ 16.64 |
0.39 % |
$ 769 M |
Nasdaq Global Select Market,SPB |
USA |
|
ProPhase Labs
PRPH
|
$ 2.18 |
2.83 % |
$ 34.5 M |
Nasdaq Capital Market |
USA |
|
Flexion Therapeutics, Inc.
FLXN
|
$ 9.12 |
- |
$ 459 M |
Nasdaq Global Market |
USA |
|
Happiness Biotech Group Limited
HAPP
|
$ 4.5 |
1.35 % |
$ 17.8 M |
Nasdaq Capital Market |
China |